Cited by 966Bone Metabolism and DiseasesBone health and osteoporosis researchBone and Dental Protein Studies

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

Poole, Kenneth E. S., Van Bezooijen, Rutger L., Loveridge, Nigel, Hamersma, Herman, Papapoulos, Socrates E., Löwik, Clemens W., Reeve, Jonathan·2005·The FASEB Journal

DOI 10.1096/fj.05-4221fje

Open this paper in CoChat — free account

Abstract

Osteocytes are the most abundant cells in bone and are ideally located to influence bone turnover through their syncytial relationship with surface bone cells. Osteocyte‐derived signals have remained largely enigmatic, but it was recently reported that human osteocytes secrete sclerostin, an inhibitor of bone formation. Absent sclerostin protein results in the high bone mass clinical disorder sclerosteosis. Here we report that within adult iliac bone, newly embedded osteocytes were negative for sclerostin staining but became positive at or after primary mineralization. The majority of mature osteocytes in mineralized cortical and cancellous bone was positive for sclerostin with diffuse staining along dendrites in the osteocyte canaliculi. These findings provide for the first time in vivo evidence to support the concept that osteocytes secrete sclerostin after they become embedded in a mineralized matrix to limit further bone formation by osteoblasts. Sclerostin did not appear to influence the formation of osteocytes. We propose that sclerostin production by osteocytes may regulate the linear extent of formation and the induction or maintenance of a lining cell phenotype on bone surfaces. In doing so, sclerostin may act as a key inhibitory signal governing skeletal microarchitecture.

Integrity signals

Registry

Crossref · 10.1096/fj.05-4221fje

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling
Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E., & Wu, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413274200 · Cited by 1,366
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
Balemans, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.5.537 · Cited by 1,147
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
Winkler, D. G., Sutherland, M. K., Geoghegan, J. C., Yu, C., Hayes, T., Skonier, J. E., Shpektor, D., Jonas, M., Kovacevich, B. R., Staehling‐Hampton, K., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg599 · Cited by 1,114
Bone Dysplasia Sclerosteosis Results from Loss of the SOST Gene Product, a Novel Cystine Knot–Containing Protein
Brunkow, M. E., Gardner, J. C., Van Ness, J., Paeper, B. W., Kovacevich, B. R., Proll, S., Skonier, J. E., Zhao, L., Sabo, P. J., Fu, Y.-H., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318811 · Cited by 1,011
Self-citation
Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist
van Bezooijen, R. L., Roelen, B. A. J., Visser, A., van der Wee-Pals, L. J. A., de Wilt, E., Karperien, M., Hamersma, H. A., Papapoulos, S. E., ten Dijke, P., & Löwik, C. W. G. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031454 · Cited by 893
Self-citation
Loss of Osteocyte Integrity in Association with Microdamage and Bone Remodeling After Fatigue In Vivo
Verborgt, O., Gibson, G. J., & Schaffler, M. B. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.1.60 · Cited by 731
Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells
Dobnig, H., & Turner, R. T. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628403 · Cited by 614
Periosteum: biology, regulation, and response to osteoporosis therapies
Allen, M. R., Hock, J. M., & Burr, D. B. (2004) · Bone · doi:10.1016/j.bone.2004.07.014 · Cited by 449
The Death of Osteocytes via Apoptosis Accompanies Estrogen Withdrawal in Human Bone
Tomkinson, A., REEVE, J., Shaw, R. W., & Noble, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4200 · Cited by 417
Self-citation

Show all 34 references

Research works printed but not linked: 2

Warmington K., 2004, Sclerostin antagonism in adult rodents, via monoclonal antibody mediated blockade, increases bone mineral density and implicates sclerostin as a key regulator of bone mass during adulthood (Abstract), J. Back Musculoskeletal. Rehabil., 19, S56
10.1210/jc.82.9.3128 · DOI

Sorted by citations

Items 501–600 of 966

Particle‐induced osteolysis is not accompanied by systemic remodeling but is reflected by systemic bone biomarkers
Ross, R. D., Virdi, A. S., Liu, S., Sena, K., & Sumner, D. R. (2014) · Journal of Orthopaedic Research® · doi:10.1002/jor.22607 · Cited by 21
Response and adaptation of bone cells to simulated microgravity
Hu, L., Li, R., Su, P., Arfat, Y., Zhang, G., Shang, P., & Qian, A. (2014) · Acta Astronautica · doi:10.1016/j.actaastro.2014.05.008 · Cited by 22
The relationship between postmenopausal women’s sclerostin levels and their bone density, age, body mass index, hormonal status, and smoking and consumption of coffee and dairy products
Kalem, M. N., Kalem, Z., Akgün, N., & Bakırarar, B. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4288-x · Cited by 21
High glucose alters the secretome of mechanically stimulated osteocyte‐like cells affecting osteoclast precursor recruitment and differentiation
Maycas, M., Portolés, M. T., Matesanz, M. C., Buendía, I., Linares, J., Feito, M. J., Arcos, D., Vallet‐Regí, M., Plotkin, L. I., Esbrit, P., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25829 · Cited by 21
Macrotopographic closure promotes tissue growth and osteogenesis in vitro
Juignet, L., Charbonnier, B., Dumas, V., Bouleftour, W., Thomas, M., Laurent, C., Vico, L., Douard, N., Marchat, D., & Malaval, L. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.02.037 · Cited by 24
Elevated levels of serum sclerostin are linked to adverse cardiovascular outcomes in peritoneal dialysis patients
Gong, L., Zheng, D., Yuan, J., Cao, L., Ni, Z., & Fang, W. (2018) · International Urology and Nephrology · doi:10.1007/s11255-018-1795-z · Cited by 21
Expression of Sclerostin in Osteoporotic Fracture Patients Is Associated with DNA Methylation in the CpG Island of the SOST Gene
Cao, Y., Wang, B., Wang, D., Zhan, D., Mai, C., Wang, P., Wei, Q., Liu, Y., Wang, H., He, W., et al. (2019) · International Journal of Genomics · doi:10.1155/2019/7076513 · Cited by 21
Exercise Alleviates Osteoporosis in Rats with Mild Chronic Kidney Disease by Decreasing Sclerostin Production
Liao, H., Huang, T., Chang, Y., Liou, H., Chou, Y.-H., Sue, Y., Hung, P., Chang, Y., Ho, P., & Tsai, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20082044 · Cited by 22
Controversies in the use of new bone‐modifying therapies in multiple myeloma
Terpos, E., & Ntanasis‐Stathopoulos, I. (2020) · British Journal of Haematology · doi:10.1111/bjh.17256 · Cited by 21
Bone structure and remodelling in stroke patients: Early effects of zoledronate
Poole, K. E. S., Vedi, S., Debiram, I., Rose, C. M., Power, J., Loveridge, N., Warburton, E. A., REEVE, J., & Compston, J. E. (2008) · Bone · doi:10.1016/j.bone.2008.11.017 · Cited by 22
Self-citation
B4GALNT3 regulates glycosylation of sclerostin and bone mass
Movérare‐Skrtic, S., Voelkl, J. G. J., Nilsson, K. H., Nethander, M., Luong, T. T. D., Alesutan, I., Li, L., Wu, J., Horkeby, K., Lagerquist, M. K., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104546 · Cited by 23
Sclerostin as a new key player in arteriovenous fistula calcification
Balcı, M. M., Kırkpantur, A., Türkvatan, A., Mandıroğlu, S., Ozturk, E., & Afşar, B. (2013) · Herz · doi:10.1007/s00059-013-3992-y · Cited by 20
Immunolocalization of DMP1 and sclerostin in the epiphyseal trabecule and diaphyseal cortical bone of osteoprotegerin deficient mice
Masuki, H., Li, M., Hasegawa, T., Suzuki, R., Guo, Y., Liu, Z., Oda, K., Yamamoto, T., Kawanami, M., & Amizuka, N. (2010) · Biomedical Research · doi:10.2220/biomedres.31.307 · Cited by 20
Application of Laser-Induced Bone Therapy by Carbon Dioxide Laser Irradiation in Implant Therapy
Naka, T., & Yokose, S. (2012) · International Journal of Dentistry · doi:10.1155/2012/409496 · Cited by 20
Sclerostin inhibits osteoblast differentiation without affecting BMP2/SMAD1/5 or Wnt3a/β-catenin signaling but through activation of platelet-derived growth factor receptor signaling in vitro
Thouverey, C., & Caverzasio, J. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.126 · Cited by 20
Analyses of bone modeling and remodeling using in vitro reconstitution system with two-photon microscopy
Hikita, A., Iimura, T., Oshima, Y., Saitou, T., Yamamoto, S., & Imamura, T. (2015) · Bone · doi:10.1016/j.bone.2015.02.030 · Cited by 20
Transcriptional activation of ENPP1 by osterix in osteoblasts and osteocytes
Gao, M., Su, Q., Liang, T., Ma, J., Stoddart, M. J., Richards, R. G., Zhou, Z., & Zou, X. (2018) · European Cells and Materials · doi:10.22203/ecm.v036a01 · Cited by 19
Sclerostin and DKK-1: two important regulators of bone metabolism in HIV-infected youths
Mora, S., Puzzovio, M., Giacomet, V., Fabiano, V., Maruca, K., Capelli, S., Nannini, P., Lombardi, G., & Zuccotti, G. (2015) · Endocrine · doi:10.1007/s12020-015-0527-8 · Cited by 20
Low Dose of Bisphosphonate Enhances Sclerostin Antibody-Induced Trabecular Bone Mass Gains in Brtl/+ Osteogenesis Imperfecta Mouse Model
Olvera, D., Stolzenfeld, R., Marini, J. C., Caird, M. S., & Kozloff, K. M. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3421 · Cited by 20
Effects of periodontal and bisphosphonate treatment on the gingival crevicular levels of sclerostin and dickkopf‐1 in postmenopausal osteoporosis with and without periodontitis
Özden, F. O., Demir, E., Lütfioğlu, M., Acarel, E. E., Bilgici, B., & Atmaca, A. A. (2022) · Journal of Periodontal Research · doi:10.1111/jre.13023 · Cited by 21
Type 2 diabetes and bone fragility in children and adults
Faienza, M. F., Pontrelli, P., & Brunetti, G. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i11.900 · Cited by 19
Meta-analysis of the effects of denosumab and romosozumab on bone mineral density and turnover markers in patients with osteoporosis
Hu, M., Zhang, Y., Guo, J., Guo, C., Yang, X., Ma, X., Xu, H., & Xiang, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1188969 · Cited by 19
Pediatric Type 1 Diabetes: Mechanisms and Impact of Technologies on Comorbidities and Life Expectancy
Urbano, F., Farella, I., Brunetti, G., & Faienza, M. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511980 · Cited by 22
Osteocyte recruitment declines as the osteon fills in: Interacting effects of osteocytic sclerostin and previous hip fracture on the size of cortical canals in the femoral neck
Power, J., Doube, M., van Bezooijen, R. L., Loveridge, N., & REEVE, J. (2012) · Bone · doi:10.1016/j.bone.2012.01.016 · Cited by 19
Self-citation
Regulation of bone resorption and mineral homeostasis by osteocytes
Pajevic, P. D. (2009) · IBMS BoneKEy · doi:10.1138/20090363 · Cited by 23
Novel bone metabolism-associated hormones: the importance of the pre-analytical phase for understanding their physiological roles
Lombardi, G., Barbaro, M., Locatelli, M., & Banfi, G. (2017) · Endocrine · doi:10.1007/s12020-017-1239-z · Cited by 19
Serum Sclerostin Level and Bone Mineral Density in Pediatric Hemophilic Arthropathy
Mikkawy, D. M. E. E., El-Badawy, M. A., El-Ghany, S. M. A., & Samaha, D. Y. (2019) · The Indian Journal of Pediatrics · doi:10.1007/s12098-019-02855-1 · Cited by 19
The promise of sclerostin inhibition for the treatment of osteoporosis
Kneissel, M. (2009) · IBMS BoneKEy · doi:10.1138/20090388 · Cited by 19
Sclerostin expression in bone tumours and tumour‐like lesions
Inagaki, Y., Hookway, E. S., Kashima, T. G., Munemoto, M., Tanaka, Y., Hassan, A. B., Oppermann, U. C. T., & Athanasou, N. A. (2016) · Histopathology · doi:10.1111/his.12953 · Cited by 19
G protein-coupled receptors as anabolic drug targets in osteoporosis
Diepenhorst, N. A., Rueda, P., Cook, A. E., Pastoureau, P., Sabatini, M., & Langmead, C. J. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.015 · Cited by 20
Association between serum and synovial fluid Dickkopf-1 levels with radiographic severity in primary knee osteoarthritis patients
Theologis, T., Efstathopoulos, N. E., Nikolaou, V. S., Charikopoulos, I., Papapavlos, I., Kokkoris, P., Παπαθεοδώρου, Α., Ansari, N. N., & Kassi, E. N. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3640-7 · Cited by 18
Aptamers for Proteins Associated with Rheumatic Diseases: Progress, Challenges, and Prospects of Diagnostic and Therapeutic Applications
Shatunova, E. A., Korolev, M. A., Omelchenko, V. O., Kurochkina, Y. D., Davydova, A., Venyaminova, A. G., & Vorobyeva, M. (2020) · Biomedicines · doi:10.3390/biomedicines8110527 · Cited by 21
Role of the Osteocyte in Musculoskeletal Disease
Shimonty, A., Bonewald, L. F., & Pin, F. (2023) · Current Osteoporosis Reports · doi:10.1007/s11914-023-00788-5 · Cited by 15
Regulation of Sclerostin Expression by Paracrine and Endocrine Factors
Sims, N. A., & Chia, L. Y. (2011) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-011-9121-7 · Cited by 18
RSK2 protects mice against TNF-induced bone loss
Böhm, C., Derer, A., Axmann, R., Hillienhoff, U., Zaiss, M. M., Luther, J., Zech, C., Stock, M., Scholtysek, C., Engelke, K., et al. (2012) · Journal of Cell Science · doi:10.1242/jcs.096008 · Cited by 18
Laser irradiation decreases sclerostin expression in bone and osteogenic cells
Ohsugi, Y., Katagiri, S., Hirota, T., Niimi, H., Hatasa, M., Watanabe, K., Shimohira, T., Mizutani, K., Kitazawa, M., Matsuzawa, A., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001032r · Cited by 19
TWEAK and TNF Regulation of Sclerostin: A Novel Pathway for the Regulation of Bone Remodelling
Findlay, D. M., & Atkins, G. J. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6612-4_34 · Cited by 17
CORRIGENDA
Gregson, C. L., Poole, K. E. S., McCloskey, E. V., Duncan, E. L., Rittweger, J., Fraser, W. D., Smith, G. D., & Tobias, J. H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3958 · Cited by 16
Self-citation
Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain
Yu, C., Xuan, M., Zhang, M., Yao, Q., Zhang, K., Zhang, X., Guo, J., & Song, L. (2017) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-017-0873-0 · Cited by 14
Monitoring multiple myeloma.
Udd, K. A., Spektor, T. M., & Berenson, J. R. (2017) · PubMed · Cited by 17
Role of histone deacetylases in bone development and skeletal disorders
Wang, J. S., Yoon, S.-H., & Wein, M. N. (2020) · Bone · doi:10.1016/j.bone.2020.115606 · Cited by 19
Molecular Signaling Pathways and Essential Metabolic Elements in Bone Remodeling: An Implication of Therapeutic Targets for Bone Diseases
Sharma, A., Sharma, L. K., & Goyal, R. (2020) · Current Drug Targets · doi:10.2174/1389450121666200910160404 · Cited by 33
Expression of sclerostin in the regenerating scales of goldfish and its increase under microgravity during space flight
Yamamoto, T., Ikegame, M., Hirayama, J., Kitamura, K.-I., Tabuchi, Y., Furusawa, Y., Sekiguchi, T., Endo, M., Mishima, H., Seki, A., et al. (2020) · Biomedical Research · doi:10.2220/biomedres.41.279 · Cited by 19
Bone signaling pathways and treatment of osteoporosis
Gogakos, A. I., Cheung, M., Bassett, J. H. D., & Williams, G. R. (2009) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.38 · Cited by 17
Increasing participation of sclerostin in postnatal bone development, revealed by three-dimensional immunofluorescence morphometry
Watanabe, T., Tamamura, Y., Hoshino, A., Makino, Y., Kamioka, H., Amagasa, T., Yamaguchi, A., & Iimura, T. (2012) · Bone · doi:10.1016/j.bone.2012.06.019 · Cited by 17
Alterations in osteocyte mediated osteoclastogenesis during estrogen deficiency and under ROCK-II inhibition: An in vitro study using a novel postmenopausal multicellular niche model
Simfia, I., Schiavi, J., & McNamara, L. M. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112005 · Cited by 17
New treatments of osteoporosis
Langdahl, B. L. (2015) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2015.07.007 · Cited by 17
Cellular Actions of Parathyroid Hormone
Kousteni, S., & Bilezikian, J. P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00049-5 · Cited by 16
Emerging Landscape of Osteogenesis Imperfecta Pathogenesis and Therapeutic Approaches
Sun, Y., Li, L., Wang, J., Liu, H., & Wang, H. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00324 · Cited by 20
Romosozumab versus parathyroid hormone receptor agonists: which osteoanabolic to choose and when?
Anastasilakis, A. D., Yavropoulou, M. P., Palermo, A., Makras, P., Paccou, J., Tabacco, G., Naciu, A. M., & Tsourdi, E. A. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae076 · Cited by 17
Basics of Bone Biology
Rauner, M., Stein, N., & Hofbauer, L. C. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0520-7_1 · Cited by 16
Role of Sclerostin in the Bone Loss of Postmenopausal Chinese Women with Type 2 Diabetes
Zhou, Y., Li, A., Song, Y., Zhou, H., Li, Y., & Tang, Y.-S. (2013) · Chinese Medical Sciences Journal · doi:10.1016/s1001-9294(13)60038-3 · Cited by 16
Changes in the intra- and peri-cellular sclerostin distribution in lacuno-canalicular system induced by mechanical unloading
Osumi, R., Wang, Z., Ishihara, Y., Odagaki, N., Iimura, T., & Kamioka, H. (2020) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-020-01135-9 · Cited by 16
Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study
Atteritano, M., Mauro, E. D., Canale, V., Bruzzese, A., Ricciardi, C. A., Cernaro, V., Lacquaniti, A., Buemi, M., & Santoro, D. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3770-9 · Cited by 15
Sclerostin Antibody Increases Callus Size and Strength but does not Improve Fracture Union in a Challenged Open Rat Fracture Model
Morse, A., McDonald, M. M., Schindeler, A., Peacock, L., Mikulec, K., Cheng, T. L., Liu, M., Ke, H. Z., & Little, D. G. (2017) · Calcified Tissue International · doi:10.1007/s00223-017-0275-2 · Cited by 15
Osteocytic perilacunar/canalicular turnover in hemodialysis patients with high and low serum PTH levels
Yajima, A., Tsuchiya, K., Burr, D. B., Minner, D. E., Condon, K. W., Miller, C. A., Satoh, S., Inaba, M., Nakayama, T., Tanizawa, T., et al. (2018) · Bone · doi:10.1016/j.bone.2018.05.002 · Cited by 15
Wnt Antagonists in Hematopoietic and Immune Cell Fate: Implications for Osteoporosis Therapies
Chicana, B. J., Donham, C., Millan, A. J., & Manilay, J. O. (2019) · Current Osteoporosis Reports · doi:10.1007/s11914-019-00503-3 · Cited by 17
Sclerostin within the chronic kidney disease spectrum
Bouquegneau, A., Evenepoel, P., Paquot, F., Malaise, O., Cavalier, E., & Delanaye, P. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.12.008 · Cited by 17
Physiologie du tissu osseux
Thomas, T., Martin, A., & Lafage‐Proust, M. (2008) · EMC - Appareil locomoteur · doi:10.1016/s0246-0521(08)40315-7 · Cited by 24
The sclerostin-neutralizing antibody AbD09097 recognizes an epitope adjacent to sclerostin's binding site for the Wnt co-receptor LRP6
Boschert, V., Frisch, C. M., Back, J. W., van Pee, K., Weidauer, S. E., Muth, E.-M., Schmieder, P., Beerbaum, M., Knappik, A., Timmerman, P., et al. (2016) · Open Biology · doi:10.1098/rsob.160120 · Cited by 17
Association of reduced sclerostin expression with collapse process in patients with osteonecrosis of the femoral head
Chen, X., Yang, F., Chen, Z., He, M., Hong, G., Huang, J.-Y., Zhou, Y., Qin, Y., Wei, Q., & He, W. (2018) · International Orthopaedics · doi:10.1007/s00264-018-3979-7 · Cited by 15
Microarray Analysis of the Role of Regional Dura Mater in Cranial Suture Fate
Kwan, M. D., Wan, D. C., Wang, Z., Gupta, D. M., Slater, B. J., & Longaker, M. T. (2008) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e31817d6244 · Cited by 15
Wnt signaling pathway and sclerostin in the development of atherosclerosis and vascular calcification
Kocełak, P., Puzianowska‐Kuźnicka, M., Olszanecka‐Glinianowicz, M., & Chudek, J. T. (2023) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/169567 · Cited by 15
Profiles of Wnt pathway gene expression during tooth morphogenesis
Raju, R., Oliver, J. D., Roth, D. M., Chattaraj, P., Kidwai, F. K., Faucz, F. R., Iben, J., Fridell, G., Dale, R., & D’Souza, R. N. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2023.1316635 · Cited by 14
Cellular Actions of PTH
Silva, B. C. C., & Kousteni, S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397166-1.00008-4 · Cited by 15
The osteocyte—A novel endocrine regulator of body phosphate homeostasis
Cheng, F., & Hulley, P. A. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.08.011 · Cited by 14
Sclerostin is essential for alveolar bone loss in occlusal hypofunction
Xu, Y., Wang, L., Sun, Y., Han, X., Gao, T., Xu, X., Tian, C., Zhao, X., Zeng, H., WANG, Y., et al. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3124 · Cited by 14
Sequencing and bioinformatics analysis of the differentially expressed genes in herniated discs with or without calcification
Shao, J., Yu, M., Jiang, L., Wu, F., & Liu, X. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2821 · Cited by 14
Application of Retinoic Acid to Obtain Osteocytes Cultures from Primary Mouse Osteoblasts
Mattinzoli, D., Messa, P., Corbelli, A., Ikehata, M., Mondini, A., Zennaro, C., Armelloni, S., Li, M., Giardino, L., & Rastaldi, M. P. (2014) · Journal of Visualized Experiments · doi:10.3791/51465 · Cited by 14
Evidence for Bone Reversal Properties of a Calcium- Collagen Chelate, a Novel Dietary Supplement
Elam, M. L. (2013) · Journal of Food & Nutritional Disorders · doi:10.4172/2324-9323.1000102 · Cited by 17
OPG and RANKL mRNA and protein expressions in the primary and secondary metaphyseal trabecular bone of PTH-treated rats are independent of that of SOST
Silvestrini, G., Ballanti, P., Sebastiani, M., Leopizzi, M., Vito, M. D., & BONUCCI, E. (2007) · Journal of Molecular Histology · doi:10.1007/s10735-007-9158-6 · Cited by 14
Sclerostin, Osteocytes, and Wnt Signaling in Pediatric Renal Osteodystrophy
Laster, M. L., Pereira, R. C., Noche, K. J., Gales, B., Salusky, I. B., & Albrecht, L. V. (2023) · Nutrients · doi:10.3390/nu15194127 · Cited by 14
Osteoporosis and Fragility in Elderly Patients
Falaschi, P., Marques, A., & Giordano, S. (2020) · Practical issues in geriatrics · doi:10.1007/978-3-030-48126-1_3 · Cited by 13
Combining sclerostin neutralization with tissue engineering: An improved strategy for craniofacial bone repair
Maillard, S., Sicard, L., Andrique, C., Torrens, C., Lesieur, J., Baroukh, B., Coradin, T., Poliard, A., Slimani, L., & Chaussain, C. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.11.046 · Cited by 13
Serum Sclerostin in Hepatitis C Virus Infected Patients
González‐Reimers, E., López-Prieto, J., Pelazas-González, R., Valls, M. R. A., de la Vega-Prieto, M. J., Jorge-Ripper, C., Durán-Castellón, M. C., & Santolaria-Fernández, F. J. (2014) · Journal of Bone Metabolism · doi:10.11005/jbm.2014.21.1.69 · Cited by 13
Pax6 Expressed in Osteocytes Inhibits Canonical Wnt Signaling
Jami, A., Gadi, J., Lee, M. J., Kim, E. J., Lee, M. J., Jung, H.-S., Kim, H., & Lim, S.-K. (2013) · Molecules and Cells · doi:10.1007/s10059-013-2310-0 · Cited by 13
Mini-implants and miniplates generate sub-absolute and absolute anchorage
Consolaro, A. G. (2014) · Dental Press Journal of Orthodontics · doi:10.1590/2176-9451.19.3.020-023.oin · Cited by 13
Flat bones and sutures formation in the human cranial vault during prenatal development and infancy: A computational model
Burgos-Flórez, F. J., Gavilán-Alfonso, M., & Garzón–Alvarado, D. A. (2016) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2016.01.006 · Cited by 13
Changes of serum sclerostin and Dickkopf-1 levels during the menstrual cycle. A pilot study
Liakou, C. G., Mastorakos, G. P., Makris, K., Fatouros, I. G., Avloniti, A. A., Marketos, H., Antoniou, J. D., Γαλανός, Α., Dontas, I. A., Rizos, D., et al. (2016) · Endocrine · doi:10.1007/s12020-016-1056-9 · Cited by 13
A novel anti-osteoporotic agent that protects against postmenopausal bone loss by regulating bone formation and bone resorption
Yang, Y., Meng, J., Hu, B., Ma, C., Zhao, C., Teng, W., Hong, J.-Q., Li, S.-H., Jiang, G., Wang, C., et al. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.08.014 · Cited by 13
Retention of osteocytic micromorphology by sclerostin antibody in a concurrent ovariectomy and functional disuse model
Zhang, D., Miranda, M., Li, X., Han, J., Sun, Y., Rojas, N., He, S., Hu, M., Lin, L., Li, X., et al. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13991 · Cited by 16
Expression of a Degradation-Resistant β-Catenin Mutant in Osteocytes Protects the Skeleton From Mechanodeprivation-Induced Bone Wasting
Bullock, W. A., Hoggatt, A. M., Horan, D. J., Lewis, K. J., Yokota, H., Hann, S., Warman, M. L., Sebastian, A., Loots, G. G., Pavalko, F. M., et al. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3812 · Cited by 16
Miniplates and mini-implants: bone remodeling as their biological foundation
Consolaro, A. G. (2015) · Dental Press Journal of Orthodontics · doi:10.1590/2177-6709.20.6.016-031.oin · Cited by 13
Sclerostin Influences Exercise-Induced Adaptations in Body Composition and White Adipose Tissue Morphology in Male Mice
Kurgan, N., Stoikos, J., Baranowski, B. J., Yumol, J., Dhaliwal, R., Sweezey-Munroe, J. B., Fajardo, V. A., Gittings, W., Macpherson, R. E. K., & Klentrou, P. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4768 · Cited by 12
Activation of connexin hemichannels enhances mechanosensitivity and anabolism in disused and aged bone
Zhao, D., Tu, C., Zhang, L., Guda, T., Gu, S., & Jiang, J. X. (2024) · JCI Insight · doi:10.1172/jci.insight.177557 · Cited by 13
The Effects of Sclerostin on the Immune System
Donham, C., & Manilay, J. O. (2020) · Current Osteoporosis Reports · doi:10.1007/s11914-020-00563-w · Cited by 12
Effects of sclerostin antibody on bone healing
Mihara, A., Yukata, K., Seki, T., Iwanaga, R., Nishida, N., Fujii, K., Nagao, Y., & Sakai, T. (2021) · World Journal of Orthopedics · doi:10.5312/wjo.v12.i9.651 · Cited by 12
Translational Strategies to Target Metastatic Bone Disease
Pagnotti, G. M., Trivedi, T., & Mohammad, K. S. (2022) · Cells · doi:10.3390/cells11081309 · Cited by 13
The synovio-entheseal complex in enthesoarthritis
Cata, A. D., Inglese, M., Rubino, R., Molinaro, F., & Mazzoccoli, G. (2015) · Clinical and Experimental Medicine · doi:10.1007/s10238-015-0341-x · Cited by 12
Romosozumab Treatment Converts Trabecular Rods into Trabecular Plates in Male Cynomolgus Monkeys
Matheny, J. B., Torres, A. M., Ominsky, M. S., & Hernandez, C. J. (2017) · Calcified Tissue International · doi:10.1007/s00223-017-0258-3 · Cited by 12
The Bromodomain Inhibitor N-Methyl pyrrolidone Prevents Osteoporosis and BMP-Triggered Sclerostin Expression in Osteocytes
Siegenthaler, B. M., Ghayor, C., Gjoksi, B., Ruangsawasdi, N., & Weber, F. E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113332 · Cited by 12
Chapter 4. Osteocytes
Bonewald, L. F. (2008) · Primer on the metabolic bone diseases and disorders of mineral metabolism · doi:10.1002/9780470623992.ch4 · Cited by 12
The role of sclerostin in lipid and glucose metabolism disorders
Jiang, H., Li, D., Han, Y., Li, N., Tao, X., Liu, J., Zhang, Z., Yu, Y., Wang, L., Yu, S., et al. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115694 · Cited by 12
Isolation, Purification, Generation, and Culture of Osteocytes
Gooi, J. H., Chia, L. Y., Vrahnas, C., & Sims, N. A. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-8997-3_3 · Cited by 11
Acceleration of orthodontic tooth movement and root resorption with near and distant surgical insults: An in-vivo study on a rat model
Mehta, S., Chen, P., Kalajzić, Ž., Ahmida, A., & Yadav, S. (2021) · International Orthodontics · doi:10.1016/j.ortho.2021.10.002 · Cited by 11
Targeting a therapeutically relevant concentration of alendronate for in vitro studies on osteoblasts
Krüger, T. B., Syversen, U., Herlofson, B. B., Lian, A., & Reseland, J. E. (2022) · Acta Odontologica Scandinavica · doi:10.1080/00016357.2022.2072522 · Cited by 11
Sclerostin antibody promotes bone formation through the Wnt/β-catenin signaling pathway in femoral trochlear after patellar instability
Xu, C., Ji, G., Chen, X., Yan, L., Liang, T., Liu, J., & Wang, F. (2022) · Connective Tissue Research · doi:10.1080/03008207.2022.2135507 · Cited by 11
Antisclerostin Effect on Osseointegration and Bone Remodeling
Couto, B. A. D. A., Fernandes, J. C. H., Saavedra-Silva, M., Roca, H., CASTILHO, R. M., & Fernandes, G. V. O. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041294 · Cited by 13
Dmp1 Promoter-Driven Diphtheria Toxin Receptor Transgene Expression Directs Unforeseen Effects in Multiple Tissues
Aljazzar, A., Javaheri, B., Prideaux, M., BOYDE, A., Scudamore, C. L., Cherifi, C., Haÿ, E., Hopkinson, M., Boyd, M. B., Cohen-Solal, M. E., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms18010029 · Cited by 11
PTH (1–34) affects bone turnover governed by osteocytes exposed to fluoride
Yu, X., Yu, H., Jiang, N., Zhang, X., Zhang, M., & Xu, H. J. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.02.014 · Cited by 11

Authors: Poole, K. E. S., Van Bezooijen, R. L., Loveridge, N., Hamersma, H., Papapoulos, S. E., Löwik, C. W., & Reeve, J.
Affiliations: University of Cambridge (GB)
Department of Endocrinology and Metabolic Diseases Leiden University Medical Centre Leiden Netherlands
South Africa
Leiden University (NL)
ORCID: Poole, Kenneth E. S.
Loveridge, Nigel
Hamersma, Herman
Papapoulos, Socrates E.
Löwik, Clemens W.
Reeve, Jonathan
Venue: The FASEB Journal
Publisher: Wiley
Published: 2005-08-25
Volume: 19
Issue: 13
Pages: 1842-1844
ISSN: 0892-6638 (ISSN-L)
1530-6860
DOI: 10.1096/fj.05-4221fje
OpenAlex: W1970864109
Cited by: 965
References: 34
Citations by year: 2026: 21 · 2025: 28 · 2024: 32 · 2023: 39 · 2022: 38 · 2021: 45 · 2020: 74 · 2019: 63 · 2018: 55 · 2017: 53 · 2016: 66 · 2015: 67 · 2014: 55 · 2013: 62 · 2012: 63
FWCI: 10.29
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: The FASEB Journal (publishedVersion)
PubMed (publishedVersion)
Funders: Medical Research Council
National Osteoporosis Society
European Commission (LSHM‐CT‐2003‐503020)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
Keywords: sclerostin, osteocytes, bone formation inhibition, sclerosteosis, osteoblasts, bone mineralization, bone lining cells, bone turnover
MeSH terms: Aged, Alkaline Phosphatase, Antibodies, Monoclonal, Biopsy, Bone and Bones, Bone Development, Bone Diseases, Developmental, Bone Resorption, Cell Differentiation, Coloring Agents, Female, Genetic Markers, Humans, Image Processing, Computer-Assisted, Immunohistochemistry, Male, Microscopy, Fluorescence, Middle Aged, Models, Biological, Osteoblasts, Osteocytes, Osteogenesis, RNA, Messenger, Time Factors, Tolonium Chloride, Signal Transduction, Bone Remodeling, Bone Morphogenetic Proteins, Adaptor Proteins, Signal Transducing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks